These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 15963288)
1. Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982-2001. Pépin J; Mpia B Emerg Infect Dis; 2005 Jun; 11(6):921-7. PubMed ID: 15963288 [TBL] [Abstract][Full Text] [Related]
2. Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo. Balasegaram M; Harris S; Checchi F; Ghorashian S; Hamel C; Karunakara U Bull World Health Organ; 2006 Oct; 84(10):783-91. PubMed ID: 17128358 [TBL] [Abstract][Full Text] [Related]
3. High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo. Robays J; Nyamowala G; Sese C; Betu Ku Mesu Kande V; Lutumba P; Van der Veken W; Boelaert M Emerg Infect Dis; 2008 Jun; 14(6):966-7. PubMed ID: 18507916 [TBL] [Abstract][Full Text] [Related]
4. Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo. Pyana Pati P; Van Reet N; Mumba Ngoyi D; Ngay Lukusa I; Karhemere Bin Shamamba S; Büscher P PLoS Negl Trop Dis; 2014 Oct; 8(10):e3212. PubMed ID: 25275572 [TBL] [Abstract][Full Text] [Related]
5. Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo. Kazumba LM; Kaka JT; Ngoyi DM; Tshala-Katumbay D PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006504. PubMed ID: 29897919 [TBL] [Abstract][Full Text] [Related]
6. Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy. Pépin J; Milord F; Khonde A; Niyonsenga T; Loko L; Mpia B Trans R Soc Trop Med Hyg; 1994; 88(4):447-52. PubMed ID: 7570842 [TBL] [Abstract][Full Text] [Related]
7. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Nok AJ Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807 [TBL] [Abstract][Full Text] [Related]
8. The phenomenon of treatment failures in Human African Trypanosomiasis. Brun R; Schumacher R; Schmid C; Kunz C; Burri C Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845 [TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo. Balasegaram M; Harris S; Checchi F; Hamel C; Karunakara U Bull World Health Organ; 2006 Oct; 84(10):777-82. PubMed ID: 17128357 [TBL] [Abstract][Full Text] [Related]
10. Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo. Pyana PP; Sere M; Kaboré J; De Meeûs T; MacLeod A; Bucheton B; Van Reet N; Büscher P; Belem AMG; Jamonneau V Infect Genet Evol; 2015 Mar; 30():128-133. PubMed ID: 25535944 [TBL] [Abstract][Full Text] [Related]
11. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo]. Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863 [TBL] [Abstract][Full Text] [Related]
12. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate. Maina N; Maina KJ; Mäser P; Brun R Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860 [TBL] [Abstract][Full Text] [Related]
13. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness. Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469 [TBL] [Abstract][Full Text] [Related]
14. [Melarsoprol]. Simon F Med Trop (Mars); 1999; 59(4):331-2. PubMed ID: 10816741 [No Abstract] [Full Text] [Related]
15. Isolation of Trypanosoma brucei gambiense from cured and relapsed sleeping sickness patients and adaptation to laboratory mice. Pyana PP; Ngay Lukusa I; Mumba Ngoyi D; Van Reet N; Kaiser M; Karhemere Bin Shamamba S; Büscher P PLoS Negl Trop Dis; 2011 Apr; 5(4):e1025. PubMed ID: 21526217 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda. Legros D; Evans S; Maiso F; Enyaru JC; Mbulamberi D Trans R Soc Trop Med Hyg; 1999; 93(4):439-42. PubMed ID: 10674099 [TBL] [Abstract][Full Text] [Related]
17. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report. Simarro PP; Asumu PN Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090 [No Abstract] [Full Text] [Related]
18. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda. Matovu E; Enyaru JC; Legros D; Schmid C; Seebeck T; Kaminsky R Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535 [TBL] [Abstract][Full Text] [Related]
19. Combination of eflornithine and melarsoprol for melarsoprol-resistant Gambian trypanosomiasis. Mpia B; Pépin J Trop Med Int Health; 2002 Sep; 7(9):775-9. PubMed ID: 12225509 [TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis. Pépin J; Mpia B Trans R Soc Trop Med Hyg; 2006 May; 100(5):437-41. PubMed ID: 16483622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]